Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Leiomyosarcoma”

203 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 203 results

Early research (Phase 1)Study completedNCT00450736
What this trial is testing

Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
University of Miami 3
Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Testing effectiveness (Phase 2)Study completedNCT00060944
What this trial is testing

Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Who this might be right for
LiposarcomaLeiomyosarcoma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 271
Testing effectiveness (Phase 2)Looking for participantsNCT04383119
What this trial is testing

Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma

Who this might be right for
Leiomyosarcoma of OvarySoft Tissue Sarcoma
Italian Sarcoma Group 100
Not applicableLooking for participantsNCT06749600
What this trial is testing

Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma

Who this might be right for
Primary Ovarian Leiomyosarcoma
Azienda USL Reggio Emilia - IRCCS 30
Large-scale testing (Phase 3)Study completedNCT02451943
What this trial is testing

Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 509
Testing effectiveness (Phase 2)UnknownNCT01883518
What this trial is testing

Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma

Who this might be right for
SarcomaNeoplasms, Connective and Soft Tissue
N.N. Petrov National Medical Research Center of Oncology 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT03719430
What this trial is testing

APX005M and Doxorubicin in Advanced Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Alexander Z. Wei, MD 27
Testing effectiveness (Phase 2)Study completedNCT00282087
What this trial is testing

Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma

Who this might be right for
LeiomyosarcomaUterine Neoplasm
Sarcoma Alliance for Research through Collaboration 47
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Looking for participantsNCT07516925
What this trial is testing

Ivonescimab in People With Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Ended earlyNCT00003054
What this trial is testing

Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Who this might be right for
Sarcoma
Gynecologic Oncology Group
Large-scale testing (Phase 3)Study completedNCT00002459
What this trial is testing

Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus

Who this might be right for
Endometrial CancerSarcoma
European Organisation for Research and Treatment of Cancer - EORTC 224
Testing effectiveness (Phase 2)Study completedNCT00004911
What this trial is testing

Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionGastric Cancer+4 more
Northwestern University
Large-scale testing (Phase 3)Study completedNCT00091351
What this trial is testing

Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis

Who this might be right for
Sarcoma
Alliance for Clinical Trials in Oncology 370
Testing effectiveness (Phase 2)Study completedNCT02406781
What this trial is testing

Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial

Who this might be right for
Sarcoma
Institut Bergonié 129
Testing effectiveness (Phase 2)Active Not RecruitingNCT03851614
What this trial is testing

Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors

Who this might be right for
Mismatch Repair Proficient Colorectal CancerPancreatic AdenocarcinomaLeiomyosarcoma
University Health Network, Toronto 90
Early research (Phase 1)Study completedNCT03761095
What this trial is testing

Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)

Who this might be right for
Leiomyosarcoma
PTC Therapeutics 41
Testing effectiveness (Phase 2)UnknownNCT03989596
What this trial is testing

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Who this might be right for
SarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more
Maria Sklodowska-Curie National Research Institute of Oncology 30
Testing effectiveness (Phase 2)Study completedNCT00949325
What this trial is testing

Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma

Who this might be right for
Sarcoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Load More Results